Notably, 322 CSR transcripts were significantly elevated in breast tumours compared to healthy breast tissue, with CEACAM6 (log2FC = 8.8), KCNJ (8.4), and CLDN6 (7.6) among the most upregulated (Fig 2D and S1 File). This evidence concerns the gene CLDN6 and breast neoplasm.